STOCK TITAN

Lilly to Participate in Goldman Sachs Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022. Key executives, Anne White and Mark Mintun, will engage in a fireside chat at 1:40 p.m. ET. Investors can listen to the event via a live audio webcast on Lilly's Investor website, with a replay available for 90 days. Founded nearly 150 years ago, Lilly is committed to advancing health solutions that positively impact over 47 million people globally. For more information, visit Lilly.com.

Positive
  • None.
Negative
  • None.

INDIANAPOLIS, June 3, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022. Anne White, senior vice president and president, Lilly Neuroscience, and Mark Mintun, senior vice president, research and development – neuroscience and president, Avid Radiopharmaceuticals, will participate in a fireside chat at 1:40 p.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn. F-LLY

Refer to:     

Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)


Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)

 

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-goldman-sachs-global-healthcare-conference-301560594.html

SOURCE Eli Lilly and Company

FAQ

When is Eli Lilly participating in the Goldman Sachs Global Healthcare Conference?

Eli Lilly will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022.

Who will represent Eli Lilly at the Goldman Sachs Conference?

Anne White and Mark Mintun will represent Eli Lilly at the conference.

What time is Eli Lilly's presentation at the conference?

Eli Lilly's presentation is scheduled for 1:40 p.m. Eastern Time.

Where can I access the live webcast of Eli Lilly's presentation?

The live audio webcast can be accessed on Lilly's Investor website.

How long will the replay of Eli Lilly's presentation be available?

The replay will be available for approximately 90 days.

Eli Lilly & Co.

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Stock Data

685.15B
950.41M
0.15%
83.46%
0.64%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
INDIANAPOLIS